Loading…
Kenvue Inc. is projected to rise to $25.04 by 2027, a +29% move from its current price of $19.48. KVUE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $19.24 | $19.49 | $19.74 | +0.04% |
| Jul 15 | $19.14 | $19.49 | $19.85 | +0.07% |
| Jul 16 | $19.07 | $19.50 | $19.94 | +0.11% |
| Jul 17 | $19.01 | $19.51 | $20.02 | +0.14% |
| Jul 18 | $18.96 | $19.51 | $20.09 | +0.18% |
| Jul 19 | $18.91 | $19.52 | $20.15 | +0.21% |
| Jul 20 | $18.87 | $19.53 | $20.21 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.87 | $19.53 | $20.21 | +0.25% |
| Week 2 | $18.65 | $19.58 | $20.55 | +0.50% |
| Week 3 | $18.49 | $19.63 | $20.83 | +0.75% |
| Week 4 | $18.37 | $19.67 | $21.07 | +1.00% |
| Week 5 | $18.27 | $19.72 | $21.29 | +1.25% |
| Week 6 | $18.18 | $19.77 | $21.50 | +1.50% |
| Week 7 | $18.10 | $19.82 | $21.70 | +1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It is categorized in the Consumer Defensive sector and runs three segments: Self Care, Skin Health and Beauty, and Essential Health.
It sells a broad range of products and brands across over‑the‑counter medicines, self-care and personal care items, cosmetics, and vitamins, including well-known names across multiple categories.
The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc.
was incorporated in 2022 and is headquartered in Summit, New Jersey.
KVUE is a consumer health stock with a current price of $19.83 per share and a market cap of $38.07B, ranking 374 by market capitalization. It sits in the Consumer Defensive category and has a price outlook shaped by a multi-year forecast showing a rising average price trajectory through 2030 and beyond.
The forecast table provides year-by-year averages that rise from 2026 onward, with notable milestones in 2030, 2040, and 2050. The 2026 average is $19.83, the 2030 average is $32.73, the 2040 average is $82.32, and the 2050 average is $161.26. The implied returns escalate across years, with ROI values of 65% by 2030, 315.1% by 2040, and 713.2% by 2050, illustrating a long‑term bullish trajectory while acknowledging these are estimates, not guarantees.
The stock market position, price level, and forecast imply a higher-price path over the coming years, but investors should consider the inherent uncertainty in long‑term projections.
A major floor 19.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 11.5% above — clearing it would confirm fresh momentum.
Key KVUE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KVUE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.46 | Buy | $19.40 | Buy |
| MA 10 | $19.38 | Buy | $19.27 | Buy |
| MA 20 | $18.84 | Buy | $18.90 | Buy |
| MA 50 | $17.98 | Buy | $18.29 | Buy |
| MA 100 | $17.89 | Buy | $18.00 | Buy |
| MA 200 | $17.30 | Buy | $18.20 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.60 | Neutral |
| Stoch RSI (14) | 43.66 | Neutral |
| CCI (20) | 77.88 | Neutral |
| Williams %R (14) | -17.77 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 5.81 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 82.23 | Sell |
| TRIX (15) | 0.37 | Buy |
| Awesome (5,34) | 1.18 | Buy |
| Ultimate (7,14,28) | 62.52 | Neutral |
| Momentum (10) | 0.52 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 19.38 | Buy |
| ADX (14) | 25.96 | Buy |
| ATR (14) | 0.24 | Info |
The 30-day technical picture is broadly bullish. The RSI(14) is 80, indicating strong upside momentum, and the stock sits above both the SMA50 of $17.78 and the SMA200 of $17.27, suggesting positive near-term trend dynamics.
Near-term support is at $16.83 and resistance at $19.83, with a 30-day range of $18.21 to $21.60. This tells us the price has recently traded near the upper end of its range, consistent with a bullish tilt but with potential pullbacks if resistance holds. The annualized volatility is around 20%, underscoring notable swings within the current trading window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.73 | $19.48 | $25.77 | 0% | Neutral | |
| $20.51 | $25.04 | $31.96 | +29% | Bullish | |
| $20.94 | $26.04 | $34.14 | +34% | Bullish | |
| $22.66 | $28.62 | $38.31 | +47% | Bullish | |
| $24.67 | $31.58 | $43.05 | +62% | Bullish | |
| $26.11 | $33.83 | $46.84 | +74% | Bullish | |
| $31.09 | $40.74 | $57.21 | +109% | Bullish | |
| $34.91 | $46.22 | $65.75 | +137% | Bullish | |
| $36.94 | $49.40 | $71.11 | +154% | Bullish | |
| $37.92 | $51.19 | $74.51 | +163% | Bullish | |
| $56.42 | $79.45 | $121.18 | +308% | Bullish | |
| $101.10 | $152.68 | $249.63 | +684% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.73 | $19.48 | $23.14 | +0.00% |
| August 2026 | $16.71 | $19.56 | $23.38 | +0.41% |
| September 2026 | $17.11 | $20.12 | $24.24 | +2.86% |
| October 2026 | $17.70 | $20.90 | $25.34 | +3.86% |
| November 2026 | $17.71 | $20.99 | $25.60 | +0.44% |
| December 2026 | $17.68 | $21.02 | $25.77 | +0.15% |
Click any year to see its month-by-month KVUE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KVUE to range from $16.73 to $25.77 through 2026. The $19.48 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The KVUE price prediction for 2027 points to an average of $25.04 (low $20.51, high $31.96) — a potential gain of +29% on today's $19.48. Buyers look set to stay in control over this stretch.
In 2028, KVUE is projected to trade between $20.94 and $34.14, averaging $26.04 — a potential gain of +34% from today's $19.48. That is up +4% on the projected 2027 average. Momentum favours further upside here.
Kenvue Inc.'s 2029 outlook centres on $28.62, within a $22.66 to $38.31 range. That is up +10% on the projected 2028 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, KVUE could reach as high as $43.05, with a base case around $31.58 and support toward $24.67 — roughly +62% from $19.48. Momentum favours further upside here.
Expect KVUE to range from $26.11 to $46.84 through 2031. The $33.83 average target implies a +74% move from current prices. That is up +7% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The KVUE price prediction for 2032 points to an average of $40.74 (low $31.09, high $57.21) — a potential gain of +109% on today's $19.48. Momentum favours further upside here.
In 2033, KVUE is projected to trade between $34.91 and $65.75, averaging $46.22 — a potential gain of +137% from today's $19.48. That is up +13% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Kenvue Inc.'s 2034 outlook centres on $49.40, within a $36.94 to $71.11 range. That is up +7% on the projected 2033 average. That marks a +154% change versus current levels. Momentum favours further upside here.
By 2035, KVUE could reach as high as $74.51, with a base case around $51.19 and support toward $37.92 — roughly +163% from $19.48. Buyers look set to stay in control over this stretch.
Expect KVUE to range from $56.42 to $121.18 through 2040. The $79.45 average target implies a +308% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
The KVUE price prediction for 2050 points to an average of $152.68 (low $101.10, high $249.63) — a potential gain of +684% on today's $19.48. Buyers look set to stay in control over this stretch.
Investing $1,000 in KVUE today (≈ 51.334702 KVUE) could be worth
$7,837.63
+$6,837.63 (+684%) by 2050 · US Dollar
Based on the average projected KVUE price of $152.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KVUEwould be worth at today's price.
$1,000 invested in KVUE on Jul 10, 2025 (≈ 47.801147 KVUE) would be worth
$931.17
-$68.83 (-6.9%) today · 0.93× · US Dollar
Based on a KVUE entry price of $20.92 vs. today's $19.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $19.83 | $982.35 | -1.8% |
| 1 month ago | $18.05 | $1,079.22 | +7.9% |
| 3 months ago | $17.35 | $1,122.77 | +12.3% |
| 6 months ago | $17 | $1,145.88 | +14.6% |
| 1 year ago | $20.92 | $931.17 | -6.9% |
| All time (3.2y) ago | $26.9 | $724.16 | -27.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KVUE forecast.
Our base-case forecast reaches $39.00 around 2032.
Implied market cap at $39.00: $74.88B
The multi-year forecast points to a bullish trajectory through 2030 and beyond. By 2030, the avg price is $32.73 with a min of $25.56 and a max of $44.63 and an ROI of 65%, supported by a continuing rise in expected value.
Looking further out, the 2040 forecast shows an avg of $82.32 with a min of $58.45 and a max of $125.60 and an ROI of 315.1%. By 2050, the avg prijs is projected to $161.26 with a min of $106.76 and a max of $263.71 and an ROI of 713.2%. These figures reflect a strong long‑term upside, though they are estimates and not guarantees.
Overall, the outlook combines a clear upward trajectory in average prices with meaningful upside potential in the max values. As with any forecast, actual results may differ, and investors should consider the inherent uncertainties when planning.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $32.73, with a min of $25.56 and a max of $44.63, and an ROI of 65%.
Forecasts indicate bullish sentiment in 2027–2050 with rising averages (e.g., 2027 avg $25.70, 2028 $26.55, 2029 $29.58, 2030 $32.73, 2040 $82.32, 2050 $161.26) and positive ROIs (e.g., 29.6% in 2027, 33.9% in 2028, 49.2% in 2029, 65% in 2030, 315.1% in 2040, 713.2% in 2050). These are estimates, not guarantees, and should be weighed against risk tolerance and other factors.
Yes. The forecast max prices include $125.60 in 2040 and $263.71 in 2050, so a $100 level is within the forecasted range.
Current price: $19.83. Market cap: $38.07B.
The 2040 forecast shows an avg price of $82.32, with a min of $58.45 and a max of $125.60, and an ROI of 315.1%.
Kenvue Inc. Community Discussion
0Share your Kenvue Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.